Incyte Corp (NASDAQ:INCY)

CAPS Rating: 2 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Recs

0
Player Avatar pchop123 (79.60) Submitted: 11/19/2012 10:52:09 AM : Outperform Start Price: $17.23 INCY Score: -7.37

potential takeover candidate

Featured Broker Partners


Advertisement